⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 20, 2021Open Access

Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer.

View Full Paper

Ask AI

Bookmark

Share

Abstract

= 0.855 and 0.684, respectively). These results show that humoral immunity beneficially influences the DDFS of patients with early TNBC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schmidt et al. (2021) studied this question.

synapsesocial.com/papers/6a736c1a9d7f0771de566642 https://doi.org/10.3390/cancers13143626

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast CancerPrognostic Study · 2008 · 862 citations
2Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative CancersPrognostic Study · 2010 · 244 citations
3A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid TumorsCohort Study · 2012 · 265 citations
4For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the TopOriginal Research · 2012 · 69 citations
5Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient populationPrognostic Study · 2018 · 74 citations